1. Hyperuricemia and Adverse Outcomes in Cardiovascular Disease

   • Andrew R. Gavin
   • Allan D. Struthers

   Current Opinion 11 September 2012 Pages: 309 - 314

   

2. Clinical Potential of Advanced Glycation End-Product Inhibitors in Diabetes Mellitus

   • Paolo Mené
   • Francescaromana Festuccia
   • Francesco Pugliese

   Leading Article 11 September 2012 Pages: 315 - 320

   

3. Immunosuppressive Therapy for Heart Failure

   • Ewa Nowalany-Kozielska
   • Romuald Wojnicz

   Leading Article 11 September 2012 Pages: 321 - 324

   

4. The Role of Lipids in the Development of Diabetic Microvascular Complications

   • Anoop Misra
   • Sumit Kumar
   • Atul Kumar

   Leading Article 11 September 2012 Pages: 325 - 338

   

5. Smoking Cessation for Patients with Cardiovascular Disease

   • Anne M. Joseph
   • Steven S. Fu

   Therapy in Practice 11 September 2012 Pages: 339 - 349

   

6. ACE Inhibition with Moexipril

   • Amos Pines
   • Enrique Z. Fisman

   Review Article 11 September 2012 Pages: 351 - 360

   

7. Assessment of Anti-Ischemic and Antianginal Effect at Trough Plasma Concentration and Safety of Trimetazidine MR 35mg in Patients with Stable Angina Pectoris

   • Philippe Sellier
   • Jean-Paul Broustet

   Original Research Article 11 September 2012 Pages: 361 - 369

   

8. Losartan

   • John Waugh
   • Gillian M. Keating

   Apis Drug Profile 11 September 2012 Pages: 371 - 377

   

9. Losartan

   • Sverre E. Kjeldsen

   Guest Commentary 11 September 2012 Pages: 378 - 378

10. Losartan

    • Jorge R. Kizer

    Guest Commentary 11 September 2012 Pages: 378 - 379

11. Spotlight on Abciximab in Patients with Ischemic Heart Disease Undergoing Percutaneous Coronary Revascularization

    • Tim Ibbotson
    • Jane K. McGavin
    • Karen L. Goa

    Apis Spotlight 11 September 2012 Pages: 381 - 386